文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气心脑血管急症

妊娠期体外膜氧合:体外生命支持组织登记数据分析

Extracorporeal Membrane Oxygenation in Pregnancy: An Analysis of the Extracorporeal Life Support Organization Registry.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论1997—2017年体外生命支持组织登记中,280例围产期接受ECMO的患者总体母体生存率为70%,体外心肺复苏、ECMO运行时长和肾脏并发症与死亡相关。

该研究为回顾性分析,基于体外生命支持组织国际登记数据库,纳入1997—2017年间所有需要ECMO的围产期患者(依据ICD-9和ICD-10标准),共280例。主要结局为住院死亡率,总体母体生存率为70%,且21年间观察到的死亡率下降。多因素回归识别出体外心肺复苏(OR 3.674,95%CI 1.425-9.473)、ECMO运行时长(<66小时为参照,66-128小时OR 0.281,95%CI 0.101-0.777)和ECMO期间肾脏并发症(OR 2.346,95%CI 1.203-4.572)为死亡的显著危险因素。静脉-静脉、静脉-动脉与混合模式之间死亡率无统计学显著差异(23.9% vs 34.4% vs 29.4%,P=0.2),肺部与心脏指征之间亦无显著差异(OR 1.634,95%CI 0.797-3.352,P=0.18)。

要点

  • 围产期接受ECMO的患者总体母体生存率为70%,21年间观察到的死亡率下降。
  • 体外心肺复苏是死亡危险因素(OR 3.674,95%CI 1.425-9.473)。
  • ECMO期间肾脏并发症与死亡相关(OR 2.346,95%CI 1.203-4.572)。
  • ECMO运行时长与死亡相关:以<66小时为参照,66-128小时OR 0.281(95%CI 0.101-0.777);128-232小时OR 0.474(95%CI 0.191-1.174);>232小时OR 1.084(95%CI 0.429-2.737)。
  • 静脉-静脉、静脉-动脉与混合ECMO模式间死亡率无统计学显著差异(23.9% vs 34.4% vs 29.4%,P=0.2)。

适用人群与场景

  • 1997—2017年间体外生命支持组织国际登记中所有需要ECMO的围产期患者,依据ICD-9和ICD-10标准识别。

研究设计与关键结果

  • 研究类型为回顾性分析,数据来自体外生命支持组织国际登记,共纳入280例围产期接受ECMO的患者。
  • 主要结局为住院死亡率,总体母体生存率为70%,21年间观察到的死亡率下降。
  • 多因素回归显示体外心肺复苏与死亡相关(OR 3.674,95%CI 1.425-9.473;总体P=0.025)。
  • ECMO运行时长与死亡相关(<66小时为参照,66-128小时OR 0.281,95%CI 0.101-0.777,P=0.014;128-232小时OR 0.474,95%CI 0.191-1.174,P=0.107;>232小时OR 1.084,95%CI 0.429-2.737,P=0.864;总体P=0.017)。
  • ECMO期间肾脏并发症与死亡相关(OR 2.346,95%CI 1.203-4.572,P=0.012)。
  • 静脉-静脉、静脉-动脉与混合ECMO模式间死亡率无统计学显著差异(23.9% vs 34.4% vs 29.4%,P=0.2)。
  • 肺部与心脏ECMO指征间死亡率无统计学显著差异(OR 1.634,95%CI 0.797-3.352,P=0.18)。

证据类型、等级与局限

  • 证据类型:回顾性分析,基于多中心数据库(体外生命支持组织国际登记)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: We examined data from the International Registry of the Extracorporeal Life Support Organization to identify risk factors for mortality in pregnant and peripartum patients receiving extracorporeal membrane oxygenation.

DESIGN: Retrospective analysis.

SETTING: International Registry of Extracorporeal Life Support Organization.

PATIENTS: We collected de-identified data on all peripartum patients who needed extracorporeal membrane oxygenation between 1997 and 2017 using International Classification of Diseases, 9th and 10th Edition criteria.

INTERVENTIONS: Our primary outcome measure was in-hospital mortality. We also collected data on demographics, preextracorporeal membrane oxygenation ventilator, hemodynamic and biochemical parameters, extracorporeal membrane oxygenation mode, duration, and complications. Initial bivariate analysis assessed potential associations between survival and various preextracorporeal membrane oxygenation as well as extracorporeal membrane oxygenation-related factors. Variables with p values of less than 0.1 were considered for logistic regression analysis which identified predictors of mortality.

MEASUREMENTS AND MAIN RESULTS: There were 280 peripartum patients who received extracorporeal membrane oxygenation. Overall maternal survival was 70%, with observed mortality for these patients decreasing over the 21-year time period. Multivariate regression identified extracorporeal cardiopulmonary resuscitation (odds ratio, 3.674; 95% CI, 1.425-9.473; overall p = 0.025), duration of extracorporeal membrane oxygenation (< 66 hr: odds ratio, 1; 66-128 hr: odds ratio, 0.281; 95% CI, 0.101-0.777; p = 0.014; 128-232 hr: odds ratio, 0.474; 95% CI, 0.191-1.174; p = 0.107; and > 232 hr: odds ratio, 1.084; 95% CI, 0.429-2.737; p = 0.864; overall p = 0.017), and renal complications on extracorporeal membrane oxygenation (odds ratio, 2.346; 95% CI, 1.203-4.572; p = 0.012) as significant risk factors for mortality. There was no statistically significant difference in mortality between venovenous versus venoarterial versus mixed group extracorporeal membrane oxygenation (23.9 vs 34.4 vs 29.4%; p = 0.2) or between pulmonary versus cardiac indications (1.634; 95% CI, 0.797-3.352; p = 0.18) for extracorporeal membrane oxygenation.

CONCLUSIONS: On analysis of this multicenter database, pregnant and peripartum patients with refractory cardiac or respiratory failure supported on extracorporeal membrane oxygenation had survival rates of 70%. We identified preextracorporeal membrane oxygenation as well as extracorporeal membrane oxygenation-related factors that are associated with mortality.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Ramanathan K, Tan CS, Rycus P, et al. Extracorporeal Membrane Oxygenation in Pregnancy: An Analysis of the Extracorporeal Life Support Organization Registry. Crit Care Med. 2020. PMID: 32191415. doi:10.1097/CCM.0000000000004269

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。